“5 Questions With…” is a weekly BioBuzz series where we reach out to interesting people in the BioHealth Capital Region and beyond to share a little about themselves, their work, and maybe something completely unrelated. This week we welcome Stephanie M. Davis, Ph.D., Program Officer, National Heart, Lung, and Blood Institute. Stay tuned for more interviews with others from across the BioHealth Capital Region and beyond.
Adaptive Phage Therapeutics Appoints Robert J. Hopkins, MD, MPH & TM, FACP, FIDSA, to Chief Medical Officer
Robert J. Hopkins, MD, MPH & TM, FACP, FIDSA, is a highly regarded medical and research professional in infectious diseases with over 25 years of industry experience
“5 Questions With…” is a weekly BioBuzz series where we reach out to interesting people in the BioHealth Capital Region to share a little about themselves, their work, and maybe something completely unrelated. This week we welcome Ronald T. Piervincenzi, Ph.D., Chief Executive Officer, United States Pharmacopeia.
5 Questions with Julie Martin, Economic Development Specialist, Montgomery County Economic Development Corporation
Julie Martin is a South African born Australian with 20 years commercial facing experience across government, private industry and the not-for-profit sectors. Julie develops investment attraction opportunities for the Montgomery County Economic Development Corporation in the state of Maryland, USA and holds a Master’s Degree in International Development from the Royal Melbourne Institute of Technology in Australia.
MITRE has named Dr. Jim Pannucci as Managing Director for Life Sciences Market Strategy, where he and his team are building an enduring line of life sciences capabilities that enable future health technologies and address unmet medical needs. Pannucci is responsible for focusing on conducting proof of concept studies, creating prototypes, applying new technologies, and closing critical knowledge gaps in the life sciences with emphasis on HHS and other USG priorities in biological sciences, medicine, preparedness, and bio-surveillance.
Azita Adli is a passionate, innovative, and quality-minded professional with 10+ years of experience within the pharmaceutical industry. Azita has held roles within production, investigation, quality systems, and central quality throughout her career, supporting sites within GlaxoSmithKline’s (GSK’s) Pharmaceutical Supply Chain.
Ed Radwinsky is a seasoned Human Resources professional with extensive experience in the biopharmaceutical and biotechnology industries. Radwinsky has a Bachelor’s in Psychology from the University of Maryland as well as a Master’s in Industrial and Organizational Psychology from the University of Tulsa. Additionally, he possesses a Senior Professional in Human Resources certification from the HR Certification Institute.
ATCC, the world’s premier biological materials management and standards organization, today announced the expanded role of Ruth Cheng, Ph.D., Chief Strategy and Innovation Officer to include duties as Vice President of Corporate Development.
ATCC, the world’s premier biological materials management and standards organization, today announced it has hired Robert Gowin as Chief Strategy Realization Officer.
5 Questions with KaShauna G. Rohlehr, Associate Director of Alliance, Program, and Project Management, GlaxoSmithKline
KaShauna G. Rohlehr is a highly motivated, results-driven technical and project management professional with 16+ years of experience in the pharmaceutical industry. Over her career, she has held positions within production, quality, technical, and supply chain organizations supporting vaccines and biopharmaceuticals manufacturing. She has been employed with GlaxoSmithKline (GSK) for 11 years, where she is currently Associate Director of Alliance, Program, and Project Management.